Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Eldorado Gold Q2 EPS $0.08 Misses $0.13 Estimate

Eldorado Gold (NYSE:EGO) reported quarterly earnings of $0.08 per share which missed the analyst consensus estimate of $0.13 by 38.46 percent. This is a 50 percent decrease over earnings of $0.16 per share from the same
byBenzinga Newsdesk
July 28, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Eldorado Gold (NYSE:EGO) reported quarterly earnings of $0.08 per share which missed the analyst consensus estimate of $0.13 by 38.46 percent. This is a 50 percent decrease over earnings of $0.16 per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

EXCLUSIVE: Fifteen New F1 Hybrid Cannabis Strains To Hit Shelves In US For 4/20 Under New Partnership

By Jelena Martinovic
April 10, 8:30 AM
California-based I Love Growing Marijuana (ILGM), announced on Tuesday an exclusive new partnership with cannabis genetics and breeding company, Phylos Bioscience, that brings 15 new F1 hybrid strains to home growers across legal markets nationwide. ILGM is launching half the collection of strains that are "crafted for potency, flavor, and diversity" on its website just in time for marijuana culture's high holiday on 4/20. In doing so, the company is leveraging Phylos Bioscience's cutting-edge technology and extensive genetic library, which Benzinga has learned exclusively. Ernst Rustenhoven, CEO of ILGM, commented on the new partnership. "ILGM caters to a customer base of novice and veteran home growers on the hunt for increasingly unique strains of superior genetics, and we have been seeking an innovative partner to help elevate and diversify our product offerings," Rustenhoven said. "In forging a relationship with Phylos, we are taking our seed catalog to the next level with a highly curated selection of sought-after F1 hybrid strains."

OGI